Laura W Dillon

17PUBLICATIONS

76CO-AUTHORS

Medical virologyMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (17)

Sort by Publication Date:

|Jun 04, 2026

ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia.

|Feb 06, 2026

Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia.

Niveditha Ravindra, Justin Lack, Clifton L Dalgard

|Nov 25, 2025

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia.

Rasha W Al-Ali, Gege Gui, Niveditha Ravindra

|Nov 14, 2025

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Steven Knapper, Laura W Dillon, Malavika Babu

|Jul 09, 2025

Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML.

Gege Gui, Molly A Bingham, Julius R Herzog

|Feb 10, 2025

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.

Athalia R Pyzer, Laura W Dillon, Elad Sharon

Pageof 3

Frequent Collaborators

13 joint publications

Christopher S Hourigan

Niveditha Ravindra

Jeffery J Auletta

Marcos J G De Lima

Steven M Devine

Partow Kebriaei

Mark R Litzow

Antonio Martin Jimenez Jimenez

3 joint publications

Stephen R Spellman

3 joint publications

Zoë Wong

Frequent Collaborators

13 joint publications

Christopher S Hourigan

6 joint publications

Niveditha Ravindra

4 joint publications

Jeffery J Auletta

4 joint publications

Marcos J G De Lima